221 related articles for article (PubMed ID: 27465638)
1. UDP-galactopyranose mutase, a potential drug target against human pathogenic nematode Brugia malayi.
Misra S; Valicherla GR; Mohd Shahab ; Gupta J; Gayen JR; Misra-Bhattacharya S
Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27465638
[TBL] [Abstract][Full Text] [Related]
2. RNA interference mediated knockdown of Brugia malayi UDP-Galactopyranose mutase severely affects parasite viability, embryogenesis and in vivo development of infective larvae.
Misra S; Gupta J; Misra-Bhattacharya S
Parasit Vectors; 2017 Jan; 10(1):34. PubMed ID: 28103957
[TBL] [Abstract][Full Text] [Related]
3. Yeast-Based High-Throughput Screens to Identify Novel Compounds Active against Brugia malayi.
Bilsland E; Bean DM; Devaney E; Oliver SG
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004401. PubMed ID: 26812604
[TBL] [Abstract][Full Text] [Related]
4. Characterization of recombinant UDP-galactopyranose mutase from Aspergillus fumigatus.
Oppenheimer M; Poulin MB; Lowary TL; Helm RF; Sobrado P
Arch Biochem Biophys; 2010 Oct; 502(1):31-8. PubMed ID: 20615386
[TBL] [Abstract][Full Text] [Related]
5. Substrate-dependent dynamics of UDP-galactopyranose mutase: Implications for drug design.
Boechi L; de Oliveira CA; Da Fonseca I; Kizjakina K; Sobrado P; Tanner JJ; McCammon JA
Protein Sci; 2013 Nov; 22(11):1490-501. PubMed ID: 23934860
[TBL] [Abstract][Full Text] [Related]
6. Contributions of unique active site residues of eukaryotic UDP-galactopyranose mutases to substrate recognition and active site dynamics.
Da Fonseca I; Qureshi IA; Mehra-Chaudhary R; Kizjakina K; Tanner JJ; Sobrado P
Biochemistry; 2014 Dec; 53(49):7794-804. PubMed ID: 25412209
[TBL] [Abstract][Full Text] [Related]
7. Cloning, expression and characterization of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Wolbachia endosymbiont of human lymphatic filarial parasite Brugia malayi.
Shahab M; Verma M; Pathak M; Mitra K; Misra-Bhattacharya S
PLoS One; 2014; 9(6):e99884. PubMed ID: 24941309
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of Trypanosoma cruzi UDP-galactopyranose mutase implicate flexibility of the histidine loop in enzyme activation.
Dhatwalia R; Singh H; Oppenheimer M; Sobrado P; Tanner JJ
Biochemistry; 2012 Jun; 51(24):4968-79. PubMed ID: 22646091
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential inhibitors for mycobacterial uridine diphosphogalactofuranose-galactopyranose mutase enzyme: A novel drug target through in silico approach.
Nayak T; Jena L; Waghmare P; Harinath BC
Int J Mycobacteriol; 2018; 7(1):61-68. PubMed ID: 29516888
[TBL] [Abstract][Full Text] [Related]
10. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.
Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA
J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454
[TBL] [Abstract][Full Text] [Related]
11. Site-directed mutagenesis of UDP-galactopyranose mutase reveals a critical role for the active-site, conserved arginine residues.
Chad JM; Sarathy KP; Gruber TD; Addala E; Kiessling LL; Sanders DA
Biochemistry; 2007 Jun; 46(23):6723-32. PubMed ID: 17511471
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures and small-angle x-ray scattering analysis of UDP-galactopyranose mutase from the pathogenic fungus Aspergillus fumigatus.
Dhatwalia R; Singh H; Oppenheimer M; Karr DB; Nix JC; Sobrado P; Tanner JJ
J Biol Chem; 2012 Mar; 287(12):9041-51. PubMed ID: 22294687
[TBL] [Abstract][Full Text] [Related]
13. Identification of eukaryotic UDP-galactopyranose mutase inhibitors using the ThermoFAD assay.
MartÃn Del Campo JS; Eckshtain-Levi M; Sobrado P
Biochem Biophys Res Commun; 2017 Nov; 493(1):58-63. PubMed ID: 28919416
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth.
Dykhuizen EC; May JF; Tongpenyai A; Kiessling LL
J Am Chem Soc; 2008 May; 130(21):6706-7. PubMed ID: 18447352
[TBL] [Abstract][Full Text] [Related]
15. Targeting UDP-galactopyranose mutases from eukaryotic human pathogens.
Kizjakina K; Tanner JJ; Sobrado P
Curr Pharm Des; 2013; 19(14):2561-73. PubMed ID: 23116395
[TBL] [Abstract][Full Text] [Related]
16. Identification and partial characterization of two eukaryotic UDP-galactopyranose mutases.
Bakker H; Kleczka B; Gerardy-Schahn R; Routier FH
Biol Chem; 2005 Jul; 386(7):657-61. PubMed ID: 16207086
[TBL] [Abstract][Full Text] [Related]
17. Search for new prototypes for the chemotherapy of filariasis: a chemotherapeutic and biochemical approach.
Bajpai P; Verma SK; Katiyar D; Tewari N; Tripathi RP; Bansal I; Saxena JK; Misra-Bhattacharya S
Parasitol Res; 2005 Apr; 95(6):383-90. PubMed ID: 15739072
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antifilarial activity of chalcone-thiazole derivatives against a human lymphatic filarial parasite, Brugia malayi.
Sashidhara KV; Rao KB; Kushwaha V; Modukuri RK; Verma R; Murthy PK
Eur J Med Chem; 2014 Jun; 81():473-80. PubMed ID: 24863844
[TBL] [Abstract][Full Text] [Related]
19. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning, purification and characterization of Brugia malayi phosphoglycerate kinase.
Kumar R; Doharey PK; Saxena JK; Rathaur S
Protein Expr Purif; 2017 Apr; 132():152-163. PubMed ID: 28192198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
